Expression of aberrant functional and nonfunctional transcripts of the FHIT gene in Burkitt's lymphomas

Molecular Carcinogenesis

Volumn 25, Issue 1, 1999, Pages 55-63

  Ferrer, Milagros ^a   López Borges, Susana ^a   Lazo, Pedro A ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Aberrant splicing; Cancer; Chromosome fragile site; FRA3B; Transcription

Indexed keywords

ARTICLE; BURKITT LYMPHOMA; CANCER GENETICS; CARCINOGENESIS; CHROMOSOME FRAGILE SITE; CHROMOSOME TRANSLOCATION; GENE DELETION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAJI CELL; SINGLE STRAND CONFORMATION POLYMORPHISM;

ACID ANHYDRIDE HYDROLASES; ALLELES; BASE SEQUENCE; BURKITT LYMPHOMA; CELL LINE; CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; CHROMOSOMES, HUMAN, PAIR 3; CODON; DNA MUTATIONAL ANALYSIS; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; NEOPLASM PROTEINS; PROTEIN BIOSYNTHESIS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING; RNA, MESSENGER; RNA, NEOPLASM; SEQUENCE DELETION; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

HUMAN HERPESVIRUS 4;

EID: 0344298950     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199905)25:1<55::AID-MC7>3.0.CO;2-3     Document Type: Article

References (35)

1. Mitelman F, Mertens F, Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 1997;15:417-474.
2. Ohta M, Inoue H, Cotticelli MG, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3:8) breakpoint, is abnormal in digestive tract cancers. Cell 1996;84:587-597.
3. Bugert P, Wilhem M, Kovacs G. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinoma. Genes Chromosomes Cancer 1997;20:9-15.
4. Man S, Ellis IO, Sibbering M, Blamey RW, Brook JD. High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. Cancer Res 1996;56:5484-5489.
5. Kastury K, Baffa R, Druck T, et al. Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. Cancer Res 1996;56:978-983.
6. Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: Direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 1996;5:187-195.
7. Druck T, Hadaczek P, Fu T-B, et al. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res 1997;57:504-512.
8. Barnes LD, Garrison PN, Siprashvili Z, et al. Fhit, a putative tumor suppressor in humans, is a dinucleotide 5′,5‴-P1 ,P3-triphosphate hydrolase. Biochemistry 1996;35:11529-11535.
9. Ong ST, Fong KM, Bader SA, et al. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines. Genes Chromosomes Cancer 1997;20:16-23.
10. Shridhar V, Wang X, Paradee W, et al. Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors. Cancer Res 1996;56:4347-4350.
11. Sozzi G, Veronese ML, Negrini M, et al. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 1996;85:17-26.
12. Fong KW, Biesterveld EJ, Virmani A, et al. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res 1997;57:2256-2267.
13. Sozzi G, Alder H, Tornielli S, et al. Aberrant FHIT transcripts in Merkel cell carcinoma. Cancer Res 1996;56:2472-2474.
14. Negrini M, Monaco C, Vorechovsky I, et al. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res 1996;56:3173-3179.
15. Hayashi S, Tanimoto K, Hajiro-Nakanishi K, et al. Abnormal FHIT transcript in human breast carcinomas: A clinicopathological and epidemiological analysis of 61 Japanese cases. Cancer Res 1997;57:1981-1985.
16. Virgilio L, Shuster M, Gollin SM, et al. FHIT gene alterations in head and neck squamous carcinoma. Proc Natl Acad Sci USA 1996;93:9770-9775.
17. Gemma A, Hagiwara K, Ke Y, et al. FHIT mutations in human primary gastric cancer. Cancer Res 1997;57:1435-1437.
18. Thiagalingam S, Lisistsyn NA, Hamaguchi M, et al. Evaluation of the FHIT gene in colorectal cancers. Cancer Res 1996;56:2936-2939.
19. Frank S, Muller J, Plaschke J, et al. The putative tumor suppressor gene FHIT at 3p 14.2 is rarely affected by loss of heterozygosity in primary human brain tumors. Cancer Res 1997; 57:2638-2641.
20. Li L, Li X, Francke U, Cohen SN. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell 1997;88:143-154.
21. Steiner P, Barnes DM, Harris WH, Weinberg RA. Absence of rearrangements in the tumor susceptibility gene TSG101 in human breast cancer. Nat Genet 1997;16:332-333.
22. Haber D, Harlow E. Tumour-suppressor genes: Evolving definitions in the genomic age. Nat Genet 1997;16:320-321.
23. Siprashvili Z, Sozzi G, Barnes LD, et al. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA 1997;94:13771-13776.
24. Otterson GA, Xiao GH, Geradts J, et al. Protein expression and functional analysis of the FHIT gene in human tumor cells. J Natl Cancer Inst 1998;90:426-432.
25. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study group. Blood 1994;84:1361-1392.
26. MaGrath I. The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 1990;53:133-270.
27. Ehlin-Henrikson B, Manneborg-Sandlund A, Klein G. Expression of B-cell-specific markers in different Burkitt lymphoma subgroups. Int J Cancer 1987;39:211-218.
28. Feduchi E, Gallego MI, Lazo PA. The human zinc finger protein-7 gene is located 90 kb 3′ of MYC and is not expressed in Burkitt lymphoma cell lines. Int J Cancer 1994;58:855-859.
29. Gallego MI, Lazo PA. Deletion in human chromosome region 12q 13-15 by integration of human papillomavirus DNA in a cervical carcinoma cell line. J Biol Chem 1995;270:24321-24326.
30. Panagopoulos I, Thelin S, Mertens F, Mitelman F, Aman P. Variable FHIT transcripts in non-neoplastic tissues. Genes Chromosomes Cancer 1997;19:215-219.
31. van den Berg A, Draaijers TG, Kok K, et al. Normal FHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region. Genes Chromosomes Cancer 1997;19:220-227.
32. Cogan JD, Prince MA, Lekhakula S, et al. A novel mechanism of aberrant pre-mRNA splicing in humans. Hum Mol Genet 1997;6:909-912.
33. Gasmi L, McLennan AG, Edwards SW. Neutrophil apoptosis is delayed by the adenosine polyphosphates. Ap5A and Ap6A: Synergism with granulocyte-macrophage colony-stimulating factor. Br J Haematol 1996;95:637-639.
34. Gasmi L, McLennan AG, Edwards SW. The adenosine polyphosphates Ap3A and Ap4A and adenosine triphosphate interact with granulocyte-macrophage colony-stimulating factor to delay apoptosis: Implications for neutrophil-platelet interactions during inflammation. Blood 1997;87:3442-3449.
35. nA), a novel class of signalling molecules? FEBS Lett 1998;427:157-163.